SEC 13F Intelligence

Boxer Capital, LLC / NRIX

Boxer Capital, LLC’s Nurix Therapeutics Inc Position

Does Boxer Capital, LLC own Nurix Therapeutics Inc (NRIX)? Not currently — the last reported position was 563.1K shares worth $13M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$13M
Q3 2024
Shares
563.1K
% of Portfolio
+0.62%
Quarters Held
14
position exited

Position History NRIX

Reported value by quarter
Q3 ’20: $47MQ3 ’20Q4 ’20: $40MQ1 ’21: $38MQ1 ’21Q2 ’21: $32MQ3 ’21: $37MQ3 ’21Q4 ’21: $35MQ1 ’22: $17MQ1 ’22Q2 ’22: $16MQ3 ’22: $16MQ3 ’22Q4 ’22: $13MQ1 ’23: $10,877Q1 ’23Q2 ’23: $12,237Q3 ’23: $10MQ3 ’23Q3 ’24: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024563.1K$13M+0.62%
Q3 20231.22M$10M+0.51%
Q2 20231.22M$12,237+0.57%
Q1 20231.22M$10,877+0.53%
Q4 20221.22M$13M+0.71%
Q3 20221.22M$16M+0.90%
Q2 20221.22M$16M+0.98%
Q1 20221.22M$17M+0.88%
Q4 20211.22M$35M+1.38%
Q3 20211.22M$37M+1.28%
Q2 20211.22M$32M+1.15%
Q1 20211.22M$38M+1.29%
Q4 20201.22M$40M+1.29%
Q3 20201.35M$47M+1.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of NRIX.